DigestRedComo funciona
Red
/
Empresas
C₂
No verificado

C₂N Diagnostics, LLC

Sobre qué escribimos

BiotecnologíaCienciaIndustriaMedicina - VariosSalud

16 Comunicados de prensa

Ver todos los comunicados de prensa
13/11/2025
Psiquiatría
Salud
Ciencia
Eventos
C2N Diagnostics and WashU Medicine Teams Receive Prestigious Award from Human Proteome Organization
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
25/09/2025
Industria
Sanidad
Tercera edad
Medicina - Varios
Ciencia
Biotecnología
Ir de compras
Salud
New Research Reinforces C2N’s PrecivityAD2™ Blood Test as a Highly Accurate Tool to Detect Brain Amyloid Pathology in Symptomatic Patients
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
03/09/2025
Dynamic Growth Leads C2N Diagnostics to Expand St. Louis Headquarters to Meet Global Need for Answers to Alzheimer’s Disease
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
25/08/2025
Sanidad
Ir de compras
Medicina - Varios
Biotecnología
Tercera edad
Salud
Industria
C2N Diagnostics Expands the PrecivityAD2™ Alzheimer’s Disease Blood Test Intended Use to Patients 50 Years and Older
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
07/08/2025
Ciencia
Psiquiatría
Medicina - Varios
Biotecnología
Sanidad
Farmacéutica
Salud
Mercado laboral
Industria
C2N Announces Major Global Expansion, Adds Six New International Partners
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
15/07/2025
Psiquiatría
Ciencia
Medicina - Varios
Biotecnología
Salud
Farmacéutica
Sanidad
Industria
C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
13/03/2025
Mercado laboral
Material médico sanitario
Salud
Sanidad
Biotecnología
Samsung Invests in C2N Diagnostics
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
24/02/2025
Biotecnología
Material médico sanitario
Sanidad
Salud
Medicina - Varios
Industria
C2N Diagnostics’ PrecivityAD2™ Blood Test Receives MHRA Medical Device Certification in the United Kingdom
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
31/01/2025
Ciencia
Biotecnología
Sanidad
Salud
Psiquiatría
Medicina - Varios
Análisis de Mercados
Industria
Study Highlights How C2N’s PrecivityAD2™ Blood Biomarker Test Use Improves Clinical Decision-Making in the Evaluation for Alzheimer’s Disease
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0
28/01/2025
Ciencia
Biotecnología
Material médico sanitario
Salud
Psiquiatría
Industria
First Canadian Clinic to Offer C2N’s PrecivityAD2™ Blood Test to Help Healthcare Providers Diagnose Alzheimer’s Disease, Joining Global Community in Embracing Breakthrough Technology
Fuente
C₂N Diagnostics, LLC
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0